These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23887158)
1. PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: A fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant. Graham RP; Weiss SW; Sukov WR; Goldblum JR; Billings SD; Dotlic S; Folpe AL Am J Surg Pathol; 2013 Nov; 37(11):1751-5. PubMed ID: 23887158 [TBL] [Abstract][Full Text] [Related]
2. Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. Gebre-Medhin S; Nord KH; Möller E; Mandahl N; Magnusson L; Nilsson J; Jo VY; Vult von Steyern F; Brosjö O; Larsson O; Domanski HA; Sciot R; Debiec-Rychter M; Fletcher CD; Mertens F Am J Pathol; 2012 Sep; 181(3):1069-77. PubMed ID: 22796436 [TBL] [Abstract][Full Text] [Related]
3. Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases. Sbaraglia M; Bellan E; Gambarotti M; Righi A; Zanatta L; Toffolatti L; Dei Tos AP Pathologica; 2020 Dec; 112(4):184-190. PubMed ID: 33179613 [TBL] [Abstract][Full Text] [Related]
5. Ossifying fibromyxoid tumor: a study of 6 cases of atypical and malignant variants. Dantey K; Schoedel K; Yergiyev O; McGough R; Palekar A; Rao UNM Hum Pathol; 2017 Feb; 60():174-179. PubMed ID: 27816723 [TBL] [Abstract][Full Text] [Related]
6. A PHF1-TFE3 fusion atypical ossifying fibromyxoid tumor with prominent collagenous rosettes: Case report with a brief review. Zou C; Ru GQ; Zhao M Exp Mol Pathol; 2021 Dec; 123():104686. PubMed ID: 34560087 [TBL] [Abstract][Full Text] [Related]
7. Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors. Atanaskova Mesinkovska N; Buehler D; McClain CM; Rubin BP; Goldblum JR; Billings SD J Cutan Pathol; 2015 Sep; 42(9):622-31. PubMed ID: 25950586 [TBL] [Abstract][Full Text] [Related]
8. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1. Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276 [TBL] [Abstract][Full Text] [Related]
9. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study. Graham RP; Dry S; Li X; Binder S; Bahrami A; Raimondi SC; Dogan A; Chakraborty S; Souchek JJ; Folpe AL Am J Surg Pathol; 2011 Nov; 35(11):1615-25. PubMed ID: 21997683 [TBL] [Abstract][Full Text] [Related]
10. Ossifying fibromyxoid tumor: morphology, genetics, and differential diagnosis. Schneider N; Fisher C; Thway K Ann Diagn Pathol; 2016 Feb; 20():52-8. PubMed ID: 26732302 [TBL] [Abstract][Full Text] [Related]
11. PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells. Hofvander J; Jo VY; Fletcher CDM; Puls F; Flucke U; Nilsson J; Magnusson L; Mertens F Mod Pathol; 2020 Jul; 33(7):1331-1340. PubMed ID: 31932680 [TBL] [Abstract][Full Text] [Related]
12. Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2. Srivastava P; Zilla ML; Naous R; Marker D; Khoshnoodi P; Burgess M; Herradura A; Wu J; Surrey LF; John I Histopathology; 2023 May; 82(6):946-952. PubMed ID: 36648026 [TBL] [Abstract][Full Text] [Related]
13. Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene. Endo M; Kohashi K; Yamamoto H; Ishii T; Yoshida T; Matsunobu T; Iwamoto Y; Oda Y Hum Pathol; 2013 Nov; 44(11):2603-8. PubMed ID: 23806526 [TBL] [Abstract][Full Text] [Related]
14. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants. Folpe AL; Weiss SW Am J Surg Pathol; 2003 Apr; 27(4):421-31. PubMed ID: 12657926 [TBL] [Abstract][Full Text] [Related]
16. Round cell tumor with a myxoid matrix harboring a PHF1-TFE3 fusion: Myoepithelial neoplasm or ossifying fibromyxoid tumor? Fei F; Prieto Granada CN; Harada S; Siegal GP; Wei S Pathol Res Pract; 2021 Sep; 225():153578. PubMed ID: 34391181 [TBL] [Abstract][Full Text] [Related]
17. Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B-BCOR and PHF1-TFE3 fusions. Linos K; Kerr DA; Baker M; Wong S; Henderson E; Sumegi J; Bridge JA J Cutan Pathol; 2020 Oct; 47(10):934-945. PubMed ID: 32352579 [TBL] [Abstract][Full Text] [Related]
18. Atypical ossifying fibromyxoid tumor unusually located in the mediastinum: report of a case showing mosaic loss of INI-1 expression. Tajima S; Koda K Int J Clin Exp Pathol; 2015; 8(2):2139-45. PubMed ID: 25973116 [TBL] [Abstract][Full Text] [Related]